Airway Therapeutics is an early stage development company that is licensing technology from within the pulmonary research program of Cincinnati Children’s Hospital Medical Center (CCHMC) for further technology ‘platform’ development. This platform will enable the development of three or more products that address various market needs in the overall market for lung disorders.